The article offers information on pharmacological advances across the world hat include scheduling and trials of efficacy of known regimens and drugs in specific situations. Topics discussed include study on the efficacy of six month-Revised U.S. National Tuberculosis Control Program (RNTCP) regimen for effusionextrapulmonary tuberculosis (EPT) in India and development of alternate drug-delivery methods for early recovery from disease.